Legacy Ventures International (LGYV) Stock Price, News & Analysis

Company Overview

Legacy Ventures International (OTCMKTS:LGYV) is a development‐stage company focused on the wellness and life sciences sectors. Founded in 2004 and headquartered in Boca Raton, Florida, the company has evolved from a small‐cap shell into an enterprise that identifies, acquires and develops businesses in health care, nutraceuticals and emerging biopharmaceutical technologies. Through strategic partnerships and in‐house research initiatives, Legacy Ventures seeks to bridge the gap between conventional medicine and natural wellness solutions.

The company’s product and service offerings span several areas, including botanical‐derived dietary supplements, herbal extracts for cognitive support and skin‐health formulations. Legacy Ventures also supports preclinical research programs aimed at novel therapeutic candidates targeting metabolic and inflammatory disorders. Its subsidiary operations encompass contract manufacturing, distribution networks and quality‐control laboratories that adhere to current Good Manufacturing Practices (cGMP).

While primarily serving the North American market, Legacy Ventures has established distribution channels in Latin America and Southeast Asia, leveraging regional supply chains for botanical raw materials. The company’s global footprint enables it to source unique plant compounds and deliver finished products to retailers, health practitioners and e-commerce platforms. In addition to product sales, Legacy Ventures provides white‐label and private‐label services to third-party brands seeking to expand their wellness portfolios.

Led by a management team with decades of experience in pharmaceutical research, regulatory affairs and consumer products, Legacy Ventures International pursues growth through targeted acquisitions, joint ventures and organic development. Under the guidance of its chief executive officer—who has overseen multiple successful product launches—the company continues to refine its R&D pipeline and expand its market reach, positioning itself as a versatile player at the intersection of natural health and biotech innovation.

Key Stats

• Today's Range: $2.50 to $2.50
• 50-Day Range: $2.50 to $2.50
• 52-Week Range: $0.55 to $2.50
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LGYV Stock Analysis - Frequently Asked Questions

How have LGYV shares performed this year?

Legacy Ventures International's stock was trading at $2.00 on January 1st, 2025. Since then, LGYV stock has increased by 25.0% and is now trading at $2.50.

How do I buy shares of Legacy Ventures International?

Shares of LGYV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Financial Services
• Industry: Shell Companies
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:LGYV
• CIK: 1616788
• Web: legacyventuresinc.com
• Phone: (523) 960-6394
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A